pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
alitretinoin
Panretin (alitretinoin)
Kaposi Sarcoma
Galephar Pharmaceutical Research Inc
5 cat
Phase 3
bevacizumab
Avastin (bevacizumab)
Melanoma
F. Hoffmann-La Roche Ltd
5 cat
Marketed
capivasertib
Truqap (capivasertib)
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$AZN
ASTRAZENECA PLC
5 cat
← prev
page 3 of 62
next →
Pain
89
Neurology
1
Marketed
epcoritamab
Epkinly (epcoritamab-bsyp)
Diffuse Large B-Cell Lymphoma
Genmab AS
5 cat
Marketed
loncastuximab tesirine
Zynlonta (loncastuximab tesirine-lpyl)
Diffuse Large B-Cell Lymphoma
$ADCT
ADC Therapeutics SA
5 cat
Marketed
mogamulizumab
Poteligeo (mogamulizumab)
Peripheral T-Cell Lymphomas (PTCL)
Kyowa Kirin Co Ltd
5 cat
Marketed
niraparib
Zejula (niraparib)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJ
JOHNSON & JOHNSON
5 cat
Marketed
FULVESTRANT
FULVESTRANT
Hormone Sensitive Breast Cancer
Eagle Pharmaceuticals Inc
4 cat
Marketed
IFOSFAMIDE
IFOSFAMIDE
Germinomatous (Seminomatous) Germ Cell Tumors
Baxter Healthcare Corp
4 cat
Marketed
OXALIPLATIN
OXALIPLATIN
Colon Cancer
Ingenus Pharmaceuticals LLC
4 cat
Marketed
lutetium Lu 177 vipivotide tetraxetan
Pluvicto (lutetium Lu 177 vipivotide tetraxetan)
Hormone-Sensitive Prostate Cancer
$NVS
NOVARTIS AG
4 cat
Marketed
momelotinib dihydrochloride
Ojjaara (momelotinib dihydrochloride)
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
GlaxoSmithKline LLC
4 cat
Marketed
polatuzumab vedotin
Polivy (polatuzumab vedotin-piiq)
Diffuse Large B-Cell Lymphoma
Genentech Inc
4 cat
Marketed
relugolix
Orgovyx (relugolix)
Prostate Cancer
Sumitomo Pharma America Inc
4 cat
Marketed
tisotumab vedotin
Tivdak (tisotumab vedotin-tftv)
Bladder Cancer
Genmab AS
4 cat
Marketed
ANAGRELIDE HYDROCHLORIDE
ANAGRELIDE HYDROCHLORIDE
Thrombosis
Takeda Pharmaceuticals USA Inc
3 cat
Marketed
Alimta
Alimta (pemetrexed disodium)
Malignant Pleural Mesothelioma
Lilly USA LLC
3 cat
Marketed
ET-800
HYDROCORTISONE
Adrenal Insufficiency
$ETON
Eton Pharmaceuticals, Inc.
3 cat
Marketed
GEMCITABINE HYDROCHLORIDE
GEMCITABINE HYDROCHLORIDE
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
$JNJ
JOHNSON & JOHNSON
3 cat
Marketed
capecitabine
Capecitabine
Colon Cancer
Armas Pharmaceuticals Inc
3 cat
Marketed
cyclophosphamide
Cyclophosphamide (cyclophosphamide [INN])
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Long Grove Pharmaceuticals LLC
3 cat
Marketed
ensartinib hydrochloride
Ensacove (ensartinib hydrochloride)
Non-Small Cell Lung Cancer
Xcovery Holdings Inc
3 cat
Marketed
futibatinib
Lytgobi (futibatinib)
Bile Duct Cancer (Cholangiocarcinoma)
Taiho Oncology Inc
3 cat
Marketed
glofitamab
Columvi (glofitamab-gxbm)
Mantle Cell Lymphoma
F. Hoffmann-La Roche Ltd
3 cat
Marketed
inavolisib
Itovebi (inavolisib)
Human Epidermal Growth Factor Receptor 2 Positive Breast…
F. Hoffmann-La Roche Ltd
3 cat
Marketed
lazertinib mesylate
Lazcluze (lazertinib mesylate)
Non-Small Cell Lung Cancer
$JNJ
JOHNSON & JOHNSON
3 cat
Marketed
mosunetuzumab
Lunsumio Velo (mosunetuzumab-axgb)
Diffuse Large B-Cell Lymphoma
Genentech Inc
3 cat
Marketed
quizartinib dihydrochloride
Vanflyta (quizartinib dihydrochloride)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Daiichi Sankyo Co Ltd
3 cat
Marketed
(abiraterone acetate + niraparib)
Akeega ((abiraterone acetate + niraparib))
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJ
JOHNSON & JOHNSON
2 cat
Marketed
(amivantamab + hyaluronidase (human recombinant))
Rybrevant Faspro ((amivantamab + hyaluronidase-rhu (human recombinant)))
Recurrent Head And Neck Squamous Cell Carcinoma
$JNJ
JOHNSON & JOHNSON
2 cat